The novel coronavirus and the disease it causes, COVID-19, have swept the world with few proven treatment options. There is also no vaccine and none is likely to be available for 1-2 years realistically. While the novel coronavirus-caused illness is generally a mild disease in kids (many of whom don’t even show symptoms), young adults, and even some middle-aged people, in older folks and those with underlying conditions it can be disastrous and even fatal.
For all these reasons, there is interest in pursuing novel treatment options including via small trials during the outbreak and stem cells have garnered quite a bit of attention here.
On this page I will be regularly updating you on developments related to stem cells and the novel coronavirus and COVID-19. Another great resource is the Washington Post’s free coronavirus coverage.
As of this update in late June, I am still somewhat skeptical about the utility of stem cells for COVID-19 but we’ll see how things look as more data accumulate.
What do you think?
Here are my past posts on this topic.
A great general resource: Research lab ramp-up plan & real-world tips to lower COVID-19 risk
June 11. June 2020 update on cells for COVID
What do you think of the promise of stem cells for the novel coronavirus? Can cells such as MSCs battle the cytokine storm associated with COVID-19? Have other positive effects? What about risks?